# About Glow Compound: an independent editorial reading-room on GLOW peptide research

> About Glow Compound — an independent editorial project publishing summaries of the peer-reviewed research on GLOW peptide and its GHK-Cu, BPC-157 and TB-500 constituents. Not a clinic, not a vendor.

An independent editorial project that sets the published research down as study plates — not a clinic, not a pharmacy, not a vendor.

## What this project is

Glow Compound is an independent editorial project that publishes summaries of the peer-reviewed research literature on GLOW peptide — the GHK-Cu + BPC-157 + TB-500 research blend — and on each of its three constituents. We read the published record and set it down plainly: what the studies measured, at what dose, in which species, and with every quantitative claim cited.

We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science, organized so a reader can see exactly where a claim comes from and how far it actually reaches.

## Why "Compound" is editorial, not a counter

The word "compound" in our name is read in its apothecary and formulary sense — a compounded preparation, an entry in the materia-medica record — not a pharmacy checkout. It is editorial framing: the position a publisher occupies relative to the literature, cataloguing and annotating it, not a claim that this site dispenses, prescribes, or supplies anything. Nothing here is for sale.

That distinction is load-bearing for GLOW specifically, because the blend is not a single approved drug and its regulatory story is mixed. We keep the [GLOW legal status and 503A compounding access](/legal-status) record in the margin precisely so the science and the regulatory facts stay separate and clearly sourced.

## How we handle the evidence

Two rules govern every page. First, we never blur the constituent and the blend: where a finding is a GHK-Cu, BPC-157 or TB-500 result, we say so, and we do not let it stand in for a blend that has never been tested as a unit [10]. Second, every quantitative claim — every dose, percentage, half-life and effect size — maps to a numbered source in the [full reference list](/references). Where the human evidence is thin, we say that plainly; recent reviews treat these compounds as investigational, and so do we [11].

The lithograph framing of this site is deliberate. A turn-of-the-century materia-medica printed a substance, its character, and the caveats attached to it as a single annotated plate — figure in the foreground, status noted in the margin. That is the register we keep: the constituents drawn as study plates, the established findings marked plainly, and the regulatory record set in the margin rather than buried. The ornament is structure, not decoration; it exists to make the hierarchy of what is known and what is merely claimed legible at a glance.

---

An illustrated night-lithograph of the GLOW peptide literature — GHK-Cu, BPC-157 and TB-500 set down as engraved study plates and weighed against their sources, with no clinic behind the gaslight and nothing here to dispense.